Enhancement of dissolution of cyclosporine a using solid dispersions with polyoxyethylene (40) stearate

Pharmazie

Volumn 61, Issue 8, 2006, Pages 681-684

  Liu, C ^a   Zhu, S J ^a   Zhou, Y ^a   Wei, Y P ^a   Pei, Yuan Ying ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; MACROGOL STEARATE;

AQUEOUS SOLUTION; ARTICLE; DISPERSION; DISSOLUTION; DRUG SOLUBILITY; IN VITRO STUDY; MICROSCOPY; SCANNING ELECTRON MICROSCOPY; X RAY DIFFRACTION;

ALGORITHMS; CHEMISTRY, PHYSICAL; CRYSTALLOGRAPHY, X-RAY; CYCLOSPORINE; DIGLYCERIDES; EXCIPIENTS; IMMUNOSUPPRESSIVE AGENTS; MICROSCOPY, ELECTRON, SCANNING; POLYETHYLENE GLYCOLS; SOLUBILITY; THERMODYNAMICS;

EID: 33748077089     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Ahmed MO (2001) Comparison of impact of the different hydrophilic carriers on the properties of piperazine-containing drug. Bur J Pharm Biopharm 51: 221-226.
2. Amidon GL, Lennernäs H, Shah VP, Crison JR (1995) A theoretical basis for biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 12: 413-420.
3. Chiu YY, Higaki K, Neudeck BL, Barnett JL, Welage LS, Amidon GL (2003) Human jejunal permeability of cyclosporin A: influence of surfactants on P-glycoprotein efflux in Caco-2 cells. Pharm Res 20: 749-756.
4. Craig DQM (2002) The mechanisms of drug release from solid dispersions in water-soluble polymers. Jut J Pharm 231: 131-144.
5. Kahan BD (1989) Cyclosporine. N Engl J Med 321: 1725-1738.
6. Kaur V, Grant DJW, Eaves T (1980) Comparison of polyethylene glycol and polyoxyethylene stearate as excipients for solid dispersion systems of Griseofulvin and Tolbutamide II: dissolution and solubility studies. J Pharm Sci 69: 1321-1326.
7. Lee EJ, Lee SW, Choi HG, Kim CK (2001) Bioavailability of cyclosporine A dispersed in sodium lauryl sulfate-dextrin based solid microspheres. Int J Pharm 218: 125-131.
8. Leuner C, Dressman J (2000) Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 50: 47-60.
9. Polli JE, Rekhi GS, Augsburger LL, Shah VP (1997) Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets. J Pharm Sci 86: 690-700.
10. Savolainen M, Khoo C, Glad H, Dahlqvist C, Juppo AM (2002) Evaluation of controlled-release polar lipid microparticles. Int J Pharm 244: 151-161.
11. Taylor NE, Mark AE, Vallat P, Brunne RM, Testa B, Van Gunteren WF (1993) Solvent dependent conformation and hydrogen bounding capacity of cyclosporin A: evidence from partition coefficient and molecular dynamic simulations. J Med Chem 36: 3753-3764.
12. Valizadeh H, Nokhodchi A, Qarakhani N, Zakeri-Milani P, Azarmi S, Hassanzadeh D, Löbenberg R (2004) Physicochemical Characterization of solid dispersions of Indomethacin with PEG 6000, Myrj 52, Lactose, Sorbitol, Dextrin, and Eudragit® E100, Drug Dev Ind Pharm 30: 303-317.